Product Images Exelon
View Photos of Packaging, Labels & Appearance
- 13.3mgcarton - 13.3mgcarton
- 4.6mgcarton - 4.6mgcarton
- 9.5mgcarton - 9.5mgcarton
- rivastigmine chemical structure - exelon patch 01
- Figure 1: Cross Section of the EXELON PATCH - exelon patch 02
- Figure 2: Rivastigmine Plasma Concentrations Following Dermal 24-Hour Patch Application - exelon patch 03
- Figure 3: Time Course of the Change from Baseline in ADAS-Cog Score for Patients Observed at Each Time Point - exelon patch 04
- Figure 4: Distribution of ADCS-CGIC Scores for Patients Completing the Study - exelon patch 05
- Cut the pouch along the dotted line and remove the patch. - exelon patch 07
- Put the sticky side of the patch on the upper or lower back, upper arm or chest and then peel off the second side of the protective liner. - exelon patch 09
- Press the patch firmly in place with the hand to make sure that the edges stick well. - exelon patch 0A
- Figure 5 Time Course of the Change from Double-Blind Baseline in ADCS-IADL Score for Patients Observed at Each Time Point in Study 2 - exelon patch 0D
- Figure 6 Time Course of the Change from Double-Blind Baseline in ADAS-Cog Score for Patients Observed at Each Time Point in Study 2 - exelon patch 0E
- Figure 7 Time Course of the Change from Baseline in SIB Score for Patients Observed at Each Time Point (Modified full analysis set–LOCF) - exelon patch 0G
- Figure 8 Time Course of the Change from Baseline in ADCS-ADL-SIV Score for Patients Observed at Each Time Point (Modified full analysis set – LOCF) - exelon patch 0H
- Figure F - exelon patch 0I
- Figure G - exelon patch 0J
- figurea - figurea
- figurec - figurec
- figureh - figureh
Product Label Images
The following 20 images provide visual information about the product associated with Exelon NDC 66758-142 by Sandoz Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
13.3mgcarton - 13.3mgcarton
This is a description for Exelon Patch, a transdermal system delivering 13.3 mg of rivastigmine over 24 hours. It is indicated for transdermal use only.*
4.6mgcarton - 4.6mgcarton
This is a set of instructions for using the Exelon Patch, a rivastigmine transdermal system. The user is guided to remove the old patch every 24 hours and apply a new one by folding and safely discarding the used patch. The text also provides contact information for more details and specifies that each system delivers 4.6 mg/24 hours for transdermal use only.*
9.5mgcarton - 9.5mgcarton
This is information about Exelon Patch, a rivastigmine transdermal system. It is used to deliver 9.5 mg of medication every 24 hours through the skin. The patch needs to be changed every 24 hours by removing the old one and applying a new one. Instructions are provided on how to discard the patch safely and wash hands with soap and water. For more details, visit the website www.sandoz.com or call 1-800-525-8747. Each package contains 30 systems.*
rivastigmine chemical structure - exelon patch 01
Figure 1: Cross Section of the EXELON PATCH - exelon patch 02
Figure 2: Rivastigmine Plasma Concentrations Following Dermal 24-Hour Patch Application - exelon patch 03
This description provides information on the levels of Rivastigmine in the given samples at different dosages. The data displays the concentrations of Rivastigmine in nanograms per milliliter for three groups: 133 mg/24 hours with n=19, 9.5 mg/24 hours with n=22, and 4.6 mg/24 hours with n=22. The values suggest a comparison between the dosage levels and their corresponding concentrations of Rivastigmine.*
Figure 3: Time Course of the Change from Baseline in ADAS-Cog Score for Patients Observed at Each Time Point - exelon patch 04
Figure 4: Distribution of ADCS-CGIC Scores for Patients Completing the Study - exelon patch 05
Cut the pouch along the dotted line and remove the patch. - exelon patch 07
This text appears to be a list of body parts where a procedure or examination may be performed. It includes options such as left or right upper arm, left or right side of chest, side, left or right upper back, and left or right lower back. This list might be used in a medical context for selecting the specific area on which a particular action needs to be performed.*
Put the sticky side of the patch on the upper or lower back, upper arm or chest and then peel off the second side of the protective liner. - exelon patch 09
This text is not readable.*
Press the patch firmly in place with the hand to make sure that the edges stick well. - exelon patch 0A
Figure 5 Time Course of the Change from Double-Blind Baseline in ADCS-IADL Score for Patients Observed at Each Time Point in Study 2 - exelon patch 0D
This text appears to be a brief summary of a clinical study comparing two different doses of a medication called "Evelon Patch," specifically the 13.3 mg dose versus the 95 mg dose. The study appears to have assessed changes in ADCS-IADL scores from baseline over the course of treatment. It also mentions "Clinical improvement" and "Clinical decline" which may indicate the study evaluated the clinical outcomes associated with the two doses of the patch.*
Figure 6 Time Course of the Change from Double-Blind Baseline in ADAS-Cog Score for Patients Observed at Each Time Point in Study 2 - exelon patch 0E
Figure 7 Time Course of the Change from Baseline in SIB Score for Patients Observed at Each Time Point (Modified full analysis set–LOCF) - exelon patch 0G
The provided text includes information on clinical statistics related to improvement seen in patients undergoing treatment for eye decline with Rivastigmine patches. It mentions LS mean difference in improvement, confidence intervals, and statistical significance levels. The data is derived from an analysis of covariance model adjusted for baseline values. The use of different sizes of Rivastigmine patches is also indicated.*
Figure 8 Time Course of the Change from Baseline in ADCS-ADL-SIV Score for Patients Observed at Each Time Point (Modified full analysis set – LOCF) - exelon patch 0H
Figure F - exelon patch 0I
Figure G - exelon patch 0J
figurea - figurea
This is a description for Pouch Exelon Patch Protective Liners that contain rivastigmine for transdermal use. The patch delivers medication through the skin. Each pouch contains 1 system with adhesive and protective liners.*
figurec - figurec
figureh - figureh
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
